Head-to-head · WeighScore
Elara MD vs Mochi Health
The verdict
Elara MD takes it — 53.5/100 to 52.3/100, but only just.
Elara MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Elara MD is a weight-loss and wellness telehealth platform offering weekly injectable GLP-1 therapy alongside a peptide menu (NAD+, sermorelin, glutathione). Mochi Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Elara MD | Mochi Health |
|---|---|---|
| WeighScore | 53.5/100 | 52.3/100 |
| Grade | C | C |
| Scorecard rank | #467 | #481 |
| Semaglutide | $249/mo (0.2 mg dose, compounded) | Not disclosed |
| Tirzepatide | $349/mo (2.0 mg dose, compounded) | Not disclosed |
| Coverage | Coverage not published | 15 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #467 · C
Strengths
- Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
- Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
- Medication included in the monthly price with free fast shipping when prescribed
- Broad reach claimed (over 40 states)
Where it loses points
- Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
- No FDA compounded-medication disclaimer published
- No named compounding pharmacy partner — prescriptions are patient-directed
- LegitScript certification, medical director, and full state list not disclosed
- Pricier than several compounded competitors
Graded #481 · C
Strengths
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Where it loses points
- Limited public information on program details
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.